ÂÜÀòÂÒÂ×

Lynn Zuchowski serves as Vice President and Chief Counsel for Severe Genetic Diseases at bluebird bio, focusing on the developmental and commercial legal support for lentiviral gene therapy products addressing significant medical needs. Zuchowski has extensive experience in cross-functional legal leadership, providing strategic guidance across various teams including Commercialization, Medical Affairs, and Compliance. Previous roles include Senior Director of Healthcare and Commercial Counsel at Bioverativ, and multiple positions at Biogen Idec where Zuchowski was deeply involved in regulatory affairs, advertising, and promotional compliance. An early career included a role as a Litigation Associate at Foley Hoag LLP where Zuchowski specialized in complex civil litigation and white-collar criminal defense. Educational qualifications encompass a JD from Suffolk University Law School, a Master's in Biology from Harvard University Extension School, and a BA in Biology from Colgate University.